These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38287827)

  • 21. M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer.
    Liu X; Ma C; Liu H; Sun Z; Luo J
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2803-2814. PubMed ID: 35596010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The N6-methyladenosine methylation landscape stratifies breast cancer into two subtypes with distinct immunological characteristics.
    Chen Y; Hou Y; Li S; Qin W; Zhang J
    Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13875. PubMed ID: 38797522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment.
    Shi Y; Wang Y; Zhang W; Niu K; Mao X; Feng K; Zhang Y
    Front Endocrinol (Lausanne); 2023; 14():1153802. PubMed ID: 37469973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma.
    Liu Z; He J; Han J; Yang J; Liao W; Chen N
    Front Immunol; 2021; 12():762243. PubMed ID: 35069534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression Profile Analysis of m6A RNA Methylation Regulators Indicates They Are Immune Signature Associated and Can Predict Survival in Kidney Renal Cell Carcinoma.
    Fang J; Hu M; Sun Y; Zhou S; Li H
    DNA Cell Biol; 2020 Oct; ():. PubMed ID: 33085515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment.
    Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y
    FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer.
    Liu J; Wang J; Wu M; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
    Front Med (Lausanne); 2021; 8():757432. PubMed ID: 35004726
    [No Abstract]   [Full Text] [Related]  

  • 28. m6A regulator-mediated methylation modification highlights immune infiltration patterns for predicting risk in hepatocellular carcinoma.
    Zhou D; Wang Y; Wei W; Zhou W; Gu J; Kong Y; Yang Q; Wu Y
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3661-3680. PubMed ID: 35972694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma.
    Xu H; Yin L; Xu Q; Xiang J; Xu R
    Cancer Cell Int; 2022 May; 22(1):199. PubMed ID: 35606813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genes associated with N6-methyladenosine regulators provide insight into the prognosis and immune response to renal clear cell carcinoma.
    Fan G; Wu D; Chen H; Wen Z; Liao L; He S; Yang J
    Environ Toxicol; 2024 Feb; 39(2):626-642. PubMed ID: 37555770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer.
    Peng B; Lin Y; Yi G; Lin M; Xiao Y; Qiu Y; Yao W; Zhou X; Liu Z
    Sci Rep; 2024 Jul; 14(1):16404. PubMed ID: 39013954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA Methylation Modification Patterns Identify Distinct Prognosis and Responses to Immunotherapy and Targeted Therapy in Renal Cell Carcinoma.
    Bai D; Cheng Y; Lu X; Namasivayam GP; Sugiyama H
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):224. PubMed ID: 37796712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N6-methyladenosine long non-coding RNAs reveal novel tool to implicate overall survival and immune microenvironment in renal clear cell carcinoma.
    Liu J; Wang J; Zhang L; Wang J; Lv Z; Zhang Y; Wang J
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4675-4687. PubMed ID: 36205842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration in Ovarian Cancer.
    Luo Y; Sun X; Xiong J
    Front Cell Dev Biol; 2021; 9():794801. PubMed ID: 35087835
    [No Abstract]   [Full Text] [Related]  

  • 36. m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma.
    Huang ZD; Lin LL; Liu ZZ; Hu C; Gu HY; Wei RX
    Front Immunol; 2021; 12():765723. PubMed ID: 35003079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.
    Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X
    Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation.
    Zhou W; Lin J; Liu J; Zhang R; Fan A; Xie Q; Hong L; Fan D
    Aging (Albany NY); 2023 Feb; 15(3):846-865. PubMed ID: 36791151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of m6A modification patterns and development of m6A-hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer.
    Shen X; Zhong J; He J; Han J; Chen N
    Front Immunol; 2022; 13():978092. PubMed ID: 36105819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. m6A Methylation Patterns and Tumor Microenvironment Infiltration Characterization in Clear-Cell Renal Cell Carcinoma.
    Ma T; Wang J; Liu X; Zhang W; Meng L; Zhang Y
    Front Genet; 2022; 13():864549. PubMed ID: 35528542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.